Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Rigel and Pfizer to collaborate in identifying drug targets in allergy and asthma

Feb. 4, 1999

Boehringer Ingelheim seeks E.U. marketing approval for non-CFC respiratory device

Feb. 3, 1999

Genome Therapeutics achieves milestone in asthma alliance with Schering-Plough

Feb. 3, 1999

Tachykinin antagonists claimed by HMR for asthma, cough, bronchitis and pain

Feb. 3, 1999

Dihydropyridines from Pfizer show excellent bradykinin-antagonist effects

Feb. 2, 1999

First market introduction for new asthma treatment --Seretide Diskus

Feb. 1, 1999

Grant will help Copernicus develop novel targeted CF gene therapy

Feb. 1, 1999

Phthalimide derivatives from JT selectively inhibit IL-5 and IgE production

Feb. 1, 1999

Novel class of PAF antagonists presented by Searle

Feb. 1, 1999

Pharmadigm enters agreement with Mipharm for PB-005

Jan. 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...